Heidi Williams

Q: What Schools Are Affiliated With Heidi Williams

Heidi Williams is affiliated with the following schools: Dartmouth College, Massachusetts Institute of Technology, Stanford University, Harvard University

Heidi Williams's AcademicInfluence.com Rankings

Heidi Williams

Economics

#1672

World Rank

#1921

Historical Rank

#701

USA Rank

economics Degrees

Download Badge

Economics

Heidi Williams's Degrees

Bachelors Economics Stanford University

Similar Degrees You Can Earn

Best Online Bachelor's of Economics for 2024

Why Is Heidi Williams Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Heidi Williams is a Professor of Economics at Dartmouth College and Director of Science Policy at the Institute for Progress. She is a graduate of Dartmouth College, and earned her MSc in development economics from Oxford University and her PhD in Economics from Harvard University. Prior to Dartmouth, Williams was the Charles R. Schwab Professor of Economics at Stanford University and an associate professor at the Massachusetts Institute of Technology. She is a member of the National Bureau of Economic Research.

(See a Problem?)

Heidi Williams's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intellectual Property Rights and Innovation: Evidence from the Human Genome (2010) (353)
Sources of Geographic Variation in Health Care: Evidence from Patient Migration (2014) (343)
Estimating Marginal Returns to Medical Care: Evidence from At-Risk Newborns (2008) (264)
Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials (2013) (190)
Who Profits from Patents? Rent-Sharing at Innovative Firms (2018) (183)
A toolkit of policies to promote innovation (2019) (165)
Advance market commitments for vaccines against neglected diseases: estimating costs and effectiveness. (2007) (115)
How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome (2015) (110)
Why Is Infant Mortality Higher in the United States Than in Europe? (2016) (99)
Incentivizing Innovation: Adding to the Tool Kit (2010) (87)
How Do Patents Affect Follow-on Innovation? Evidence from the Human Genome. (2019) (71)
How Do Patents Affect Research Investments? (2017) (71)
Innovation Inducement Prizes: Connecting Research to Policy (2012) (66)
Place-Based Drivers of Mortality: Evidence from Migration (2019) (66)
Creating Markets for Vaccines (2006) (54)
The More We Die, the More We Sell? A Simple Test of the Home-Market Effect (2016) (49)
Adjusting Risk Adjustment - Accounting for Variation in Diagnostic Intensity. (2017) (41)
Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments (2014) (38)
Toward a more scientific science (2018) (33)
The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism (2012) (31)
Do firms underinvest in long-term research? Evidence from cancer clinical trials. (2015) (28)
What Drives Prescription Opioid Abuse? Evidence from Migration (2018) (27)
Female labor force participation (2015) (26)
Why is Infant Mortality Higher in the Us than in Europe? (2014) (25)
The role of hospital heterogeneity in measuring marginal returns to medical care: a reply to Barreca, Guldi, Lindo, and Waddell. (2011) (24)
Patents and Research Investments: Assessing the Empirical Evidence (2016) (23)
Advance Market Commitments: A Policy to Stimulate Investment in Vaccines for Neglected Diseases (2006) (22)
Screening and Selection: The Case of Mammograms (2019) (20)
Intellectual Property Rights and Innovation: Evidence from Health Care Markets (2015) (18)
Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs (2017) (14)
Contracting Over the Disclosure of Scientific Knowledge: Intellectual Property Protection and Academic Publication (2010) (10)
Optimal Vaccine Subsidies for Endemic and Epidemic Diseases (2020) (9)
Innovation: Market Failures and Public Policies (2021) (6)
PATENT RIGHTS AND INNOVATION BY SMALL AND LARGE FIRMS (2015) (6)
Advance Market Commitments (2011) (5)
Incentivizing Education: Adding to the Toolkit (2010) (5)
Internalizing Externalities: Designing Effective Data Policies (2020) (4)
Patents and Research Investments: What Inventions Are We Missing? (2016) (2)
Optimal Subsidies for Prevention of Infectious Disease (2020) (2)
What Drives Risky Prescription Opioid Use? Evidence from Migration (2022) (2)
Advance Market Commitments for Vaccines Working Paper and Spread Sheet (2006) (2)
Comment on "Income, Aging, Health and Well-Being around the World: Evidence from the Gallup World Poll" (2010) (1)
Incentivizing Innovation : Adding to the Tool Kit Author ( s ) : (2010) (1)
1 Incentivizing Innovation : Adding to the Tool Kit (2010) (1)
Essays on technological change in health care markets (2010) (1)
Early life determinants of long-run outcomes (2015) (1)
Optimal vaccine subsidies for endemic diseases (2022) (1)
Corrigendum to “Who Profits from Patents?” (2021) (1)
Replication data for: Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs (2019) (0)
The art of management (2017) (0)
Firm-level determinants of wages and productivity : Rent-sharing (2015) (0)
Comment on Innovation and Entrepreneurship in Health Care (2020) (0)
“FIT”: FIELD EXPERIMENTAL EVIDENCE ON CREATIVE WORKER SORTING ON AN INNOVATION TASK (2011) (0)
Replication data for: A Toolkit of Policies to Promote Innovation (2019) (0)
Replication data for: How Do Patents Affect Follow-On Innovation? Evidence from the Human Genome (2019) (0)
Equalizing wage differentials (2015) (0)
Private and Public Investments in Biomedical Research (2021) (0)
Targeting Precision Medicine: Evidence from Prenatal Screening (2022) (0)
Discrimination : Theory (2015) (0)
Response to USPTO Request for Comments on Patent Eligibility Jurisprudence Study (2021) (0)
Preliminary*and*incomplete.*do*not*cite*or*circulate*without*permission* * 0* * Healthcare Exceptionalism? Productivity and Allocation in the U.s. Healthcare Sector + * Preliminary*and*incomplete.*do*not*cite*or*circulate*without*permission* * 1* * (2012) (0)
The Origins of Task-Biased Technical Change (2011) (0)
Self-selection : The Roy model (2015) (0)
Comment on "Aging and Death under a Dollar a Day" (2010) (0)
Intergenerational mobility : Theory , measurement , and empirics (2015) (0)
Discrimination and learning (2015) (0)
Heidi Louise Williams, piano (2011) (0)
Firm-level determinants of wages and productivity : Management practices (2015) (0)
Replication data for: Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials (2019) (0)
NBER WORKING PAPER SERIES TARGETING PRECISION MEDICINE: EVIDENCE FROM PRENATAL SCREENING (2022) (0)
Standing on the Shoulders of Scotchmer: The Empirical Economics of Cumulative Innovation (2017) (0)
Creating Markets for Vaccines (Innovations Case Discussion: International AIDS Vaccine Initiative) (2006) (0)
14.662 S15 Labor Economics II Lecture 18 (2015) (0)
Targeting Precision Medicine: Evidence from Prenatal Screening PRELIMINARY ... SOME PARTS ARE STILL INCOMPLETE/IN-PROGRESS (2022) (0)
CEP Discussion Paper No 1634 July 2019 A Toolkit of Policies to Promote Innovation (2019) (0)
Underinvest in Long-Term Research ? Evidence from Cancer Clinical Trials (2015) (0)

This paper list is powered by the following services:

Other Resources About Heidi Williams

What Schools Are Affiliated With Heidi Williams?

Heidi Williams is affiliated with the following schools:

Heidi Williams's Academic­Influence.com Rankings